Results 1 to 10 of about 19,736 (150)

Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations

open access: yesInsights into Imaging, 2021
Uveal melanoma is a malignant neoplasm that derives from pigmented melanocytes of the uvea and involves, in order of decreasing prevalence, the choroid, ciliary body and iris.
Pietro Valerio Foti   +16 more
doaj   +1 more source

Immunohistochemical Expression of ABCB5 as a Potential Prognostic Factor in Uveal Melanoma

open access: yesApplied Sciences, 2019
Uveal melanoma represents the most common primary intraocular malignancy in adults; it may arise in any part of the uveal tract, with choroid and ciliary bodies being the most frequent sites of disease.
Giuseppe Broggi   +7 more
doaj   +1 more source

The clinical and histopathological features of patients with both uveal and cutaneous melanoma

open access: yesThe Pan-American Journal of Ophthalmology, 2020
Introduction: It is unusual to have uveal and cutaneous melanoma in the same patient. It is challenging to differentiate between primary uveal melanoma (UM) and melanoma metastatic to the uvea.
Anelise Savaris Dias   +7 more
doaj   +1 more source

Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: To describe two cases of medium-sized uveal melanoma presenting with hemorrhagic choroidal detachments. Observations: The first case is a 39-year-old man who presented with choroidal hemorrhage and angle closure glaucoma. The second case is a 42-
Yewlin E. Chee   +8 more
doaj   +1 more source

Necrotic uveal melanoma presenting as orbital cellulitis with intraocular hemorrhage: A case report

open access: yesAmerican Journal of Ophthalmology Case Reports, 2019
Purpose: To report a case of necrotic uveal melanoma presenting as orbital cellulitis with an intraocular hemorrhage. Observations: A 61 year-old non-verbal male presented with a two-week history of right eyelid swelling and erythema unresponsive to ...
Alexa L. Li   +4 more
doaj   +1 more source

BAP1 methylation: a prognostic marker of uveal melanoma metastasis

open access: yesnpj Precision Oncology, 2021
Uveal melanoma, the most common intraocular primary cancer in adults, is characterized by striking variability in metastatic tendencies. BAP1 deletion in the primary tumor is associated with uveal melanoma metastasis, but it cannot always be resolved by ...
Mathieu F. Bakhoum   +3 more
doaj   +1 more source

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. [PDF]

open access: yesPLoS ONE, 2012
Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of ...
Rosaria Gangemi   +18 more
doaj   +1 more source

Uveal melanoma incidentally diagnosed with neuroimaging, a case series of 3 patients

open access: yesRadiology Case Reports, 2022
Uveal melanoma is the most common primary intraocular malignancy and can occur in the choroid, the ciliary body, or the iris. It is most often diagnosed based on clinical examination by an ophthalmologist. Nearly all patients present with visual symptoms.
Mai Tsukikawa, MD   +4 more
doaj   +1 more source

Uveal melanoma: Estimating prognosis

open access: yesIndian Journal of Ophthalmology, 2015
Uveal melanoma is the most common primary malignant tumor of the eye in adults, predominantly found in Caucasians. Local tumor control of uveal melanoma is excellent, yet this malignancy is associated with relatively high mortality secondary to ...
Swathi Kaliki   +2 more
doaj   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy